Want to join the conversation?
$JNJ CFO Dominic Caruso said the company's pharmaceutical business continued its strong performance into 1Q16, with underlying operational growth at over 12%. At 1Q16-end, the company had approx. $17Bil of net cash. Through the end of 1Q16, $JNJ completed approx. 25% of its $10Bil share repurchase program and expects to complete 75% by 2016-end.
$MON shares dip slightly; I wonder this is because of the environmental lawsuit filed by the Washington state against the production of PCBs.
My bet is that $FR will reach $32 in the short term. It’s time it broke the 52-week high and had its fair share of growth.
$WYNN got bruised up by China after its decision to cut withdrawal limit in Macau ATMs. Wynn Resorts shares went down by more than 11%! Well who could have guessed that right?